Online Courses

"Your Educational Journey Starts Here"

Cardiovascular Pharmacology Clinical Update Series

These classes were recorded in 2020!  The following 4 topics are included in this series.

  • Antiarrhythmic Pharmacology
  • Antiplatelet and Anticoagulant Medications
  • Heart Failure Pharmacology
  • Diabetes Medications

Customers may purchase a video or audio only version of the recording.  A pdf of course materials is included with either purchase option.

Continuing Education:
8.45 hours of continuing education (contact hours) are offered with this program, which includes 8.45 hour of pharmacology CE applicable to APRN practice. CNEA is a provider approved by the California Board of Registered Nursing, provider number 15714.

Class descriptions for each individual class are included below.

 

Antiarrhythmic Pharmacology: Enhancing Your Clinical Decision Making

Presented by: Karen Marzlin

Course Description:
Antiarrhythmic agents are used in the emergent and long-term management of atrial and ventricular arrhythmias. These high-risk medications carry a potential for the development of life-threatening arrhythmias due to their powerful impact on the action potential. For this reason, these agents require a high level of clinical knowledge for effective prescribing, administration, patient counseling, and evaluation.  During this session, Karen will enhance your understanding of these medications by using the link between the cardiac action potential and the drug mechanism of action, to provide a physiological framework. Antiarrhythmic medications used in the treatment of atrial, ventricular, and other cardiac arrhythmias will be included in this program. Agents are discussed by classification with characteristics and nursing implications of specific agents highlighted. Clinical decision making is guided by algorithm, based on patient and drug specific features. The results of recent clinical trials for newer antiarrhythmic agents are integrated into the discussion of literature. Evidence from the American College of Cardiology, American Heart Association, and Heart Rhythm Society for the management of supraventricular, atrial, and ventricular arrhythmias serve as the foundation for clinical recommendations. Join Karen as she simplifies complex medications in a manner that will aid you in clinical decision making when it comes to antiarrhythmic medications. From the novice APRN to the most experienced there is something for everyone to learn.

Learning Objectives:
Upon completion of this course, the participant will be able to:
1.  Correlate the action of antiarrhythmic agents with their effect on the action potential.
2.  Discuss the role of antiarrhythmic agents in the management of atrial, ventricular, and other cardiac arrhythmias.
3.  Describe key considerations in prescribing, administering, and evaluating the effect of antiarrhythmic medications.

 

Diabetic Medications: The Endocrine, Cardiac and Renal Connection

Presented by: Cynthia Webner

Course Description:
The research is exploding as we learn more and more everyday about sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor analogues and their impact on diabetes, cardiovascular disease, heart failure and kidney disease. The trifecta of diabetes, renal dysfunction and cardiovascular disease is common in many patients.  During this session Cindy will discuss these diabetic agents and their implication in the cardiac patient a well as patients with chronic kidney disease both with diabetes and without.  Join Cindy as she unwraps this new data and provides valuable information that will be applicable to your practice.  From the novice APRN to the most experienced there is something for everyone to learn.

Learning Objectives:
1.  Correlate the different classes of medications used in the treatment of diabetes mellitus to their mechanism of action.
2.  Review the basic algorithm used in the management of patients with diabetes mellitus type 2.
3.  Discuss clinical trials showing evidence of cardiovascular benefit in medications used to treat diabetes mellitus type 2.
4.  Discuss clinical trials showing evidence of renal benefit in medications used to treat diabetes mellitus type 2.

 

Antiplatelet and Anticoagulation Pharmacology: Navigating the Complexities

Presented by: Cynthia L. Webner DNP, CCNS, ACNP-AG, CCRN-CMC, CHFN

Course Description:
Fibrinolytics, antiplatelet and anticoagulants are not interchangeable medications. Understanding the right situation for use can impact lives. This 2-hour webinar will discuss when to use fibrinolytics, when to use anticoagulants, and when to used antiplatelet medications in patients with acute coronary syndromes, atrial fibrillation, stroke, or venous thromboembolic disease. With patient safety being a high priority, this webinar will discuss safe practice including assessing risk versus benefits, essentials for prescribing, issues in administration, evaluation of effectiveness, and monitoring for adverse outcomes. The challenges of triple therapy will be discussed. Cindy concludes with case studies to help with practical application. From the novice APRN to the most experienced there is something for everyone to learn.

Learning Objectives:
Upon completion of this course, the participant will be able to:
1.  Apply principles of clotting to the therapeutic use of fibrinolytic agents, anticoagulants, and antiplatelet medications.
2.  Correlate the therapeutic action of fibrinolytic agents, anticoagulants, and antiplatelet medications with treatment strategies in acute coronary syndromes, atrial fibrillation, stroke and venous thromboembolic disease.
3.  Discuss safety concerns when prescribing fibrinolytic agents, anticoagulants, and antiplatelet medications.
4. Review the clinical approach when bleeding occurs in patients taking fibrinolytic agents, anticoagulants, and antiplatelet medications.

 

Heart Failure Pharmacology: Integrating the New with the Old

Presented by: Karen Marzlin

Course Description:
With the emergence of new therapies for the treatment of heart failure, the provider is challenged with the best ways to effectively use medications to improve outcomes and symptoms in patients with heart failure.  This 2-hour pharmacology webinar will focus on the old standbys – betablockers, RAAS inhibitor, mineralocorticoid receptor antagonists and diuretics as well as the newer agents – Sacubitril/Valsartan Entresto, Ivabradine (Corlanor), and SGLT2 inhibitors.  Karen will provide pearls and pitfalls associated with the complicated juggling act of determining which is the right therapeutic regimen for your patient including decision making regarding initiation, up titration, discontinuation, and monitoring. Join us for this jam-packed webinar full of practical tips that will take your practice to a new level of confidence. From the novice APRN to the most experienced there is something for everyone to learn.

Learning Objectives:
Upon completion of this course, the participant will be able to:
1.  Evaluate the therapeutic use of guideline directed medical therapy in impacting the neurohormonal response in heart failure.
2.  Outline strategies for initiation and uptitration of medication-based therapies in patients with heart failure.
3.  Examine strategies for treating patients demonstrating signs and symptoms of heart failure decompensation.
4.  Discuss emerging medications demonstrating improved outcomes in patients with heart failure.

 

Online classes are available for 12 month access.

Recorded Video Price:
Click here for video price

Recorded Audio Price:
Click here for audio price

Excellence Starts Here

Keep up-to-date with live classes, products, promotions, practice pearls and online courses.

Sign up today and receive a FREE GIFT, an exclusive offer available only to new subscribers:

Top 10 Lessons Learned in over 100 years of Combined Nursing Experience

Cardiovascular Nursing Education Associates

Exceptional Nurses, Exceptional Patient Care

(206) 403-3486

info@cardionursing.com

3324 SW 172nd St. Burien, WA 98166